Skip to content

Allobaculum stercoricanis and Its Postbiotics Alleviate Dextran Sulfate Sodium (DSS)-Induced Colitis through the Regulation of theTLR4/NF-κB Signaling Pathway.

Oct 2026 · Journal of Agricultural and Food Chemistry · Vol 74 43, pp. 33790-33804 · 0 citations · 50 references
Medicine

TL;DR

It is demonstrated that live Allobaculum stercoricanis and its two postbiotic preparations and its two postbiotic preparationseffectively alleviated dextran sulfate sodium (DSS)-induced colitis in mice, and hypothesize that α-MCA may contribute to ameliorating intestinal inflammation through engagement of FXR and suppression of the TLR4/NF-κB signaling pathway.

Abstract

Inflammatory bowel disease (IBD) is a chronic intestinal disorder that has become a global public health concern. Postbiotics offer advantages in biosafety and reproducibility over probiotics. Here, we demonstrated that live Allobaculum stercoricanis (A. stercoricanis) and its two postbiotic preparations─inactivated bacterial cells (POST) and cell-free fermentation supernatant (CFS)─effectively alleviated dextran sulfate sodium (DSS)-induced colitis in mice. Integrated gut microbiome and serum metabolomics analyses indicated that these interventions may act through modulating bile acid metabolism and Toll-like receptor signaling pathways. Further investigations combining postbiotic metabolomics, network pharmacology, molecular docking, and molecular dynamics simulations identified α-muricholic acid (α-MCA) as a candidate functional metabolite, with the farnesoid X receptor (FXR) as a potential target. We hypothesize that α-MCA may contribute to ameliorating intestinal inflammation through engagement of FXR and suppression of the TLR4/NF-κB signaling pathway. These findings provide new insights into postbiotic-based therapeutic strategies for IBD.

View source

Similar papers

Open access Oct 2026

Lacticaseibacillus paracasei JY062 postbiotic ameliorates DSS-induced colitis in mice through the miR-6974-5p/IL-17A/MAPK/AP-1 axis

It is demonstrated that Pa JY062 ameliorates DSS-induced colitis by upregulating miR-6974-5p, which directly targets IL-17A and suppresses the downstream MAPK/AP-1 signaling pathway, revealing a novel miRNA-dependent mechanism that provides a scientific basis for developing functional foods and miRNA-targeted therapies...

Jin-Feng Guo, Yun-Lei Chai, Kai-Qi Gao et al. · 0 citations
Oct 2026

Forsythiae Fructus polysaccharides mitigate DSS colitis by modulating gut microbiota-derived palmitic acid and PI3K/AKT pathway.

Inflammatory bowel disease (IBD) is a chronic inflammatory disorder with limited therapeutic options, and the contribution of microbiota-associated metabolites to disease progression remains incompletely understood. Here, we demonstrate that Forsythia polysaccharides (FPs) exert protective effects against dextran sulfa...

Peng Cheng, Ying Huang, Yi-Xiang Luo et al. · 0 citations
Open access Nov 2026

Faecalibacterium prausnitzii-associated 18β-glycyrrhetinic acid protects against sepsis via ABCC1-mediated suppression of MAPK/NF-κB signaling

ABSTRACT Gut microbiota dysbiosis is increasingly recognized as a modifiable determinant of sepsis susceptibility and outcomes, yet protective commensals and microbiota-associated metabolites with actionable host mechanisms remain incompletely defined. Here, fecal 16S rRNA sequencing of septic and non-septic patients r...

Hong Wang, Ao-Lin Jiang, Yi He et al. · 0 citations
Open access Nov 2026

Atractylodes macrocephala Koidz . Polysaccharide Ameliorates Colitis via Microbiota-Independent Activation of Autophagy and Induction of Mucin 2 Secretion

Ulcerative colitis (UC) is a chronic inflammatory bowel disease featured by impaired colonic mucus barrier dominated by MUC2. Dietary polysaccharides alleviate UC mainly via gut microbiota fermentation, but their direct effects on goblet cells remain unclear. Here, we identified a low-molecular-weight (2.68 kDa) in...

Yi-Mu Ma, Zhi-Hua Wang, Ya-Qi Tong et al. · 0 citations
Nov 2026

Azelaic Acid Mediates the Protective Effect of Lactiplantibacillus plantarum F1m against Colitis via PPARγ Activation.

It is found that F1m enhances AzA production by modulating gut microbiota, thereby protecting against colitis via PPARγ activation, and indicates that F1m enhances AzA production by modulating gut microbiota, thereby protecting against colitis via PPARγ activation.

Dan Jia, Yuan Han, Zhi Li et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.